| Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group H Trimarchi, J Barratt, DC Cattran, HT Cook, R Coppo, M Haas, ZH Liu, ... Kidney international 91 (5), 1014-1021, 2017 | 1050 | 2017 |
| Remission of proteinuria improves prognosis in IgA nephropathy HN Reich, JW Scholey, DC Cattran Journal of the American Society of Nephrology 18 (12), 3177-3183, 2007 | 777 | 2007 |
| KDIGO 2021 clinical practice guideline for the management of glomerular diseases BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ... Kidney international 100 (4), S1-S276, 2021 | 655 | 2021 |
| Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ... Kidney international 100 (4), 753-779, 2021 | 630 | 2021 |
| IgA nephropathy JC Rodrigues, M Haas, HN Reich Clinical Journal of the American Society of Nephrology 12 (4), 677-686, 2017 | 597 | 2017 |
| Rituximab or cyclosporine in the treatment of membranous nephropathy FC Fervenza, GB Appel, SJ Barbour, BH Rovin, RA Lafayette, N Aslam, ... New England Journal of Medicine 381 (1), 36-46, 2019 | 529 | 2019 |
| Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial J Lv, H Zhang, MG Wong, MJ Jardine, M Hladunewich, V Jha, ... Jama 318 (5), 432-442, 2017 | 519 | 2017 |
| Evaluating a new international risk-prediction tool in IgA nephropathy SJ Barbour, R Coppo, H Zhang, ZH Liu, Y Suzuki, K Matsuzaki, ... JAMA internal medicine 179 (7), 942-952, 2019 | 403 | 2019 |
| Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury DW Wong, GY Oudit, H Reich, Z Kassiri, J Zhou, QC Liu, PH Backx, ... The American journal of pathology 171 (2), 438-451, 2007 | 334 | 2007 |
| Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach CA Gadegbeku, DS Gipson, LB Holzman, AO Ojo, PXK Song, L Barisoni, ... Kidney international 83 (4), 749-756, 2013 | 324 | 2013 |
| Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease HN Reich, GY Oudit, JM Penninger, JW Scholey, AM Herzenberg Kidney international 74 (12), 1610-1616, 2008 | 302 | 2008 |
| The MEST score provides earlier risk prediction in lgA nephropathy SJ Barbour, G Espino-Hernandez, HN Reich, R Coppo, ISD Roberts, ... Kidney international 89 (1), 167-175, 2016 | 296 | 2016 |
| Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis GY Oudit, AM Herzenberg, Z Kassiri, D Wong, H Reich, R Khokha, ... The American journal of pathology 168 (6), 1808-1820, 2006 | 296 | 2006 |
| Venous thromboembolism in patients with membranous nephropathy S Lionaki, VK Derebail, SL Hogan, S Barbour, T Lee, M Hladunewich, ... Clinical Journal of the American Society of Nephrology 7 (1), 43-51, 2012 | 257 | 2012 |
| Validation of the Oxford classification of IgA nephropathy AM Herzenberg, AB Fogo, HN Reich, S Troyanov, N Bavbek, AE Massat, ... Kidney international 80 (3), 310-317, 2011 | 251 | 2011 |
| Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial DZI Cherney, CCJ Dekkers, SJ Barbour, D Cattran, AHA Gafor, ... The lancet Diabetes & endocrinology 8 (7), 582-593, 2020 | 237 | 2020 |
| Proteinuria reduction as a surrogate end point in trials of IgA nephropathy A Thompson, K Carroll, LA Inker, J Floege, V Perkovic, S Boyer-Suavet, ... Clinical Journal of the American Society of Nephrology 14 (3), 469-481, 2019 | 233 | 2019 |
| Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis SJ Barbour, A Greenwald, O Djurdjev, A Levin, MA Hladunewich, ... Kidney international 81 (2), 190-195, 2012 | 233 | 2012 |
| Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial J Lv, MG Wong, MA Hladunewich, V Jha, LS Hooi, H Monaghan, M Zhao, ... Jama 327 (19), 1888-1898, 2022 | 232 | 2022 |
| IgA nephropathy: core curriculum 2021 P Pattrapornpisut, C Avila-Casado, HN Reich American Journal of Kidney Diseases 78 (3), 429-441, 2021 | 229 | 2021 |
